Loading...
Loading IPO details...

INVICTA
LISTEDInvestors can bid for minimum 1600 shares (2 lots min for Individual) and in multiples. The table shows min-max investment by Individual and HNI.
| Application | Lots | Shares | Amount |
|---|---|---|---|
Individual(min) | 2 | 3,200 | ₹2.72L |
Individual(max) | 2 | 3,200 | ₹2.72L |
SHNI(min) | 3 | 4,800 | ₹4.08L |
SHNI(max) | 7 | 11,200 | ₹9.52L |
BHNI(min) | 8 | 12,800 | ₹10.88L |
Note: Lot size is 1600 shares at ₹85/share (₹₹1.36L/lot). SME: 2 lots minimum. Limits: Individual ₹0-₹2L, sHNI ₹2L-₹10L, bHNI >₹10L.
Invicta Diagnostic Limited operates a hub-and-spoke diagnostic chain focused on radiology and pathology services, with revenue primarily from B2C individual tests (around 87-92%) and advanced imaging driving higher margins. Revenue grew 90% from ₹15.90 crores to ₹30.18 crores in FY25, with PAT up 30% YoY. The SME IPO is sized at ₹28.12 crores with a price band of ₹80-85 per share.
Despite strong growth, low subscription (1.19x), minimal GMP (₹3), and heavy B2C reliance pose risks in a volatile SME segment. Valuation is fair but lacks strong demand for sustained gains; better opportunities exist elsewhere.
Analyst Notes: Automated research generated via Perplexity AI